Current or Recent MG Research & Studies
Looking for an open research study to join? CLICK HERE
Hot MG Research News (MGFA)
American Journal of Managed Care (AJMC) Search for "Myasthenia Gravis"
Vol. 4 No. 3 (2023): Proceedings of the MGFA International Conference (KU)
Overview of MG Research and Clinical Trials (Conquer MG)
MG Research (NIH via PubMed)
Newly discovered mechanisms of action by Soliris (Eculizumab) may improve treatment outcomes (unboundmedicine)
Role of complement in myasthenia gravis (Frontiersin)
Myasthenia gravis: the role of complement at the neuromuscular junction (New York Academy of Sciences)
Complement and its role in innate and adaptive immune responses (Cell Research)
*NEW* COUR (MGFA/YouTube) "Reprogramming the Immune System to Halt Myasthenia Gravis"
FDA OKs clinical testing of new cell therapy for hard-to-treat gMG (Myasthenia Gravis News)
Povetacicept shows promise in MG mouse model (Myasthenia Gravis News)
Press Release (Business wire)
Povetacicept may be superior to current MG treatments: Early study (Myasthenia gravis News)
UK Study: Most Patients With MG Require Hospitalization, Driving Health Care Resource Use (AJMC)
Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy (Heliyon)
How physicians with poor knowledge of MG might affect care of MG patients (unboundmedicine) - subscription required
People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population (unboundmedicine) - subscription required
Healthcare resource use in myasthenia gravis: a US health claims analysis (PubMed)
How characterizing Social Determinants Of Health burden can help improve the design of patient support programs (unboundmedicine) - subscription required
Results from the MyRealWorld MG study (unboundmedicine) - subscription required
An innovative partnership between Alexion, AstraZeneca Rare Disease and patients (unboundmedicine) - subscription required
Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients (MDPI)
Mental Health Toll Reported in Patients With Myasthenia Gravis (rarediseaseadvisor)
Patients With MG Have High Levels of Neuroticism, Study Finds (rarediseaseadvisor)
Personality factors in patients with myasthenia gravis: A prospective study (onlinelibrary)
Personality traits in MG patients may underlie depression, anxiety (Myasthenia Gravis News)
Scientists Discover “Startling” Levels of Hidden Mental Health Symptoms Among Autoimmune Disease Patients (SciTechDaily)
*NEW* Phase 1 trial of NKX019 cell therapy in gMG patients cleared to open (Myasthenia Gravis News)
Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis (PubMed)
Worsening of myasthenic symptoms associated with statins (PubMed)
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis (Wiley)
Abnormalities of Otoacoustic Emissions in Myasthenia Gravis: Association With Serological and Electrophysiological Features (Frontiers in Neurology) Results of this research that suggest a test for the ears that might improve the "diagnostic certainty of MG and help to monitor its severity".
Taste disorders and alopecia in myasthenia gravis (BMC Neurology)
Patient perceptions of disease burden and treatment of myasthenia gravis based on sentiment analysis of digital conversations (Nature) - An analysis of "...public domain digital conversations about MG..." from online sources such as MG forums and social media.
What's on the Horizon for Myasthenia Gravis (MedPage Today)
Antigenic mimicry of ubiquitin by the gut bacterium Bacteroides fragilis: a potential link with autoimmune disease (Clinical and Experimental Immunology)
MicroRNAs in blood may help diagnose ocular MG, study suggests (Myasthenia Gravis News) (here is the original study article)
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows (mdpi)
Lack of exercise may play a role in the development of MG (NIH)
Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics (translationalmedicine)
In Myasthenia Gravis, Antibodies Pass Open-Label Tests (Medscape) - subscription required
GRO Biosciences’ ProGly platform shows promise in MG animal model (Myasthenia Gravis News)
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis (Center watch.com)
FLEX Study (to test the effectiveness and safety of batoclimab, the investigational injectable medication)
Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort study (nmd-journal)
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials (Neurology.org)
Recipharm, Ahead team up to develop new treatment for MG (Myasthenia Gravis News)
*NEW* Complement Inhibitor Gefurulimab Meets End Points in Phase 3 PREVAIL Study of Myasthenia (Neurology Live)
IM-101 showed higher C5 inhibitory activity in preclinical studies (Myasthenia Gravis News)
miR-125a-5p Regulates Treg Function by Targeting Foxp3 in Experimental Autoimmune Myasthenia Gravis Mice (ScienceDirect)
HNSA-5487 shows antibody-lowering abilities in clinical trial (Myasthenia Gravis News)
Inebilizumab reduces gMG severity in Phase 3 trial: Top-line data (Myasthenia Gravis News) "Therapy effective against both AChR, MuSK antibody-positive patients" See also: Anti-CD19 Monoclonal Antibody Shows Positive Results in Myasthenia Gravis
Immune Checkpoint Discovery Has Implications for Treating Cancer and Autoimmune Diseases (NIH)
Satralizumab (Neuromuscular Disorders)
Results of Phase III Study of Enspryng (Satralizumab) in Patients with Generalized Myasthenia Gravis (Synapse) Also, Satralizumab Fails to Reach Expected Clinical Benefit in LUMINESCE Study of Myasthenia Gravis (NeurologyLive)
The Intricate Dance of Non-Coding RNAs in Myasthenia Gravis Pathogenesis and Treatment (Frontiers in Immunology) "Research highlights aberrant ncRNAs in MG pathogenesis, suggesting their potential as biomarkers"
FDA Greenlights NMD670 Phase 2b Trial in US Myasthenia Gravis Patients (Synapse)
$105M raised to support clinical trial of CNP-106 in gMG patients (Myasthenia Gravis News) This is the COUR study.
TOL2 tolerated well in preclinical study (Myasthenia Gravis News)
Kyverna to conduct Phase 2 trial of cell therapy KYV-101 in MG (Myasthenia Gravis News)
CABA-201 to be tested in patients with, without antibodies targeting AChR (Myasthenia Gravis News)
Remission of severe myasthenia gravis after autologous stem cell transplantation (Wiley)
‘Inverse vaccine’ may reverse symptoms in autoimmune diseases... (Medical News Today)